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Background: Yijin-tang (YJ) has been used traditionally for the treatment of cardiovascular
conditions, nausea, vomiting, gastroduodenal ulcers, and chronic gastritis. In this study, a
simple and sensitive high-performance liquid chromatography (HPLC) method was  devel-
oped  for the quantitation of nine bioactive compounds in YJ: homogentisic acid, liquiritin,
naringin, hesperidin, neohesperidin, liquiritigenin, glycyrrhizin, 6-gingerol, and pachymic
acid.
Methods: Chromatographic separation of the analytes was achieved on an RS Tech C18 column
(4.6 mm × 250 mm, 5 m) using a mobile phase composed of water containing 0.1% (v/v)
triﬂuoroacetic acid (TFA) and acetonitrile with a gradient elution at a ﬂow rate of 1.0 mL/min.
Results: Calibration curves for all analytes showed good linearity (R2 ≥ 0.9995). Lower limits
of  detection and lower limits of quantiﬁcation were in the ranges of 0.03–0.17 g/mL and
0.09–0.43 g/mL, respectively. Relative standard deviations (RSDs; %) for intra- and interday
assays were < 3%. The recovery of components ranged from 98.09% to 103.78%, with RSDs
(%)  values ranging from 0.10% to 2.59%.
Conclusion: This validated HPLC method was applied to qualitative and quantitative analysesof  nine bioactive compounds in YJ and fermented YJ, and may be a useful tool for the quality
control of YJ.
© 2016 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license∗ Corresponding authors: KM Application Center, Korea Institute of Orie
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.  Introduction
ijin-tang (YJ, Erchen-tang in Chinese, Nichin-to in Japanese) is
 traditional prescription for the prevention and treatment
f diverse diseases; it has been used widely to treat nau-
ea, vomiting, gastroduodenal ulcers, and chronic gastritis.1
J has also been shown to improve digestive function in
linical research trials. Recently, YJ was reported to show
herapeutic effects on diseases of the circulatory system
nd protective effects against gastric mucosa in in vivo
xperiments.2,3 YJ is composed of Pinellia ternata Breiten-
ach, Citrus unshiu Markovich, Poria cocos Wolf, Glycyrrhiza
ralensis Fisch, and Zingiber ofﬁcinale Roscoe, according to the
orean Herbal Pharmacopeia. The major components of each
erbal medicine in YJ are known to be bioactive components,
ncluding ﬂavonoids (e.g., liquiritin, liquiritigenin, hesperidin,
utin, naringin, neohesperidin, and poncirin), triterpenoids
e.g., glycyrrhizin, pachymic acid, and eburicoic acid), phe-
olic acids (e.g., homogentisic acid), and pungent principles
e.g., 6-gingerol and 6-shogaol).4–10 These compounds, derived
rom each herbal medicine, have various pharmacological
ctivities including anticancer, -inﬂammatory, -bacterial, and
oxidant activities.4,11–16 In this study, speciﬁc biomarkers
ere selected to evaluate the quality of YJ and its ingredients,
ncluding homogentisic acid for P. ternata Breitenbach, hes-
eridin, naringin and neohesperidin for C. unshiu Markovich,
achymic acid for P. cocos Wolf, liquiritigenin and glycyrrhizin
or G. uralensis Fisch, and 6-gigerol for Z. ofﬁcinale Roscoe
Table 1).
Several analytical methods for these compounds have
een developed for qualitative and quantitative analyses
sing high-performance liquid chromatography-diode-array
etector (HPLC-DAD) and liquid chromatography/mass spec-
rometry (LC/MS).17–25 However, these methods cannot
imultaneously determine the multiple bioactive components
n YJ. Although a HPLC-DAD method to detect six compounds
n YJ was recently developed, the identiﬁcation and quantiﬁ-
ation of compounds based on retention times and UV spectra
re limited due to the interference of nontarget molecular
omponents in YJ.26 Therefore, methods for simultaneously
etecting these biomarkers in YJ is needed to ensure efﬁcient
uality control and pharmaceutical evaluation using LC/MS.
In this study, a rapid, simple, and efﬁcient analytical
ethod for nine biomarkers in YJ was developed using
Table 1 – Composition and biomarkers of ﬁve herbal
medicines in Yijin-tang
Herbal medicine Amount (g) Ratio Biomarkers
Pinellia ternata
Breitenbach
800  41.0 Homogentisic
acid
Citrus unshiu
Markovich
400  20.5 Hesperidin,
naringin,
neohesperidin
Poria cocos Wolf 400 20.5 Pachymic acid
Glycyrrhiza uralensis
Fisch
200  10.3 Liquiritigenin,
glycyrrhizin
Zingiber ofﬁcinale
Roscoe
150  7.7 6-Gingerol141
HPLC-DAD for quantitation and LC/MS for identiﬁcation. Sub-
sequently, the method was applied to chemically proﬁle
targeted analytes in YJ and Lactobacillus-fermented YJ.
2.  Materials  and  methods
2.1.  Chemicals  and  reagents
Homogentisic acid, liquiritin, naringin, neohesperidin, and tri-
ﬂuoroacetic acid (TFA) were purchased from Sigma-Aldrich Co.
(St. Louis, MO, USA.). Liquiritigenin, 6-gingerol, and pachymic
acid were obtained from Faces Biochemical Co., Ltd. (Wuhan,
China). Hesperidin and glycyrrhizin were purchased from ICN
Biomedicals (Santa Ana, CA, USA) and Tokyo Chemical Indus-
try Co., Ltd. (Tokyo, Japan), respectively. The purity of all
standards was > 97%. All herbal medicines were purchased
at the Yeongcheon traditional herbal market (Yeongcheon,
South Korea). The chemical structures of the nine bioactive
compounds are shown in Fig. 1. HPLC-grade acetonitrile was
purchased from J.T. Baker Inc. (Philipsburg, NJ, USA). Deion-
ized water was prepared using an ultrapure water production
apparatus (Millipore, Billerica, MA, USA).
2.2.  Preparation  and  fermentation  of  YJ
All herb samples were purchased from the Yeongcheon Herbal
Store (Yeongcheon, South Korea) and all specimens (#50 for P.
ternata Breitenbach, #22 for C. unshiu Markovich, #61 for P. cocos
Wolf, #3 for G. uralensis Fisch, and #6 for Z. ofﬁcinale Roscoe)
were stored in the herbarium of the KM Application Cen-
ter, Korea Institute of Oriental Medicine. Five medicinal herbs
(1.95 kg, Table 1) were extracted in 19.5 L of distilled water for
3 hours using a COSMOS-660 extractor (Kyungseo Machine Co.,
Incheon, Korea). Extracts were sieved (106 m)  to yield 15.8 L
of the decoction. To ferment YJ, 10 bacterial strains (includ-
ing Lactobacillus rhamnosus KFRI 144, Lactobacillus acidophilus
KFRI 150, Lactobacillus amylophilus KFRI 161, L. acidophilus KFRI
162, Lactobacillus plantarum KFRI 166, L. acidophilus KFRI 217,
Lactobacillus brevis KFRI 221, L. brevis KFRI 227, Lactobacillus cur-
vatus KFRI 231, and L. acidophilus KFRI 341) were obtained from
the Korean Food Research Institute (Seongnam, Korea). Bacte-
rial strains were cultured in de Man, Rogsa and Sharpe (MRS)
broth at 37 ◦C for 24 hours and viable cell counts of each strain
were determined in triplicate using a pour plate method on
MRS  agar. Solutions of YJ extracts were adjusted to pH 8 using
1 M sodium hydroxide and autoclaved for 15 minutes at 121 ◦C.
Sterilized-YJ solutions (500 mL)  were inoculated with 5 mL  of
the inoculum (1% v/v, 2 × 109 CFU/mL). Inoculated samples
were incubated at 37 ◦C for 48 hours and a brownish powder
of fermented YJ extract was obtained via lyophilization. These
fermented YJ (f-YJ) samples were stored at 4 ◦C before use.
2.3.  Preparation  of  calibration  standards,  quality
control,  and  analytical  samplesStandard stock solutions of the nine bioactive standards—
homogentisic acid, liquiritin, naringin, hesperidin, neohes-
peridin, liquiritigenin, glycyrrhizin, 6-gingerol, and pachymic
acid—were prepared at concentrations of 200 g/mL,
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Fig. 1 – Chemical structures of the nine compounds (1, homogentisic acid; 2, liquiritin; 3, naringin; 4, hesperidin; 5,
l, anneohesperidin; 6, liquiritigenin; 7, glycyrrhizin; 8, 6-gingero
200 g/mL, 200 g/mL, 800 g/mL, 200 g/mL, 200 g/mL,
600 g/mL, 200 g/mL, and 400 g/mL, respectively, by dis-
solving them in methanol. The nine bioactive standards were
mixed from stock solutions and then diluted serially to ﬁve
concentrations for the construction of calibration curves.
Quality control samples for method validation were prepared
at three serially diluted concentrations. The standard stock
solutions, calibration standards, and quality control samples
were stored at 4 ◦C before use. The YJ powder and f-YJ (1.0 g)
were weighed exactly and dissolved at a concentration of
5 mg/mL  in 50% methanol. After dissolution, the samples were
centrifuged (8,000 g, 10 minutes, 25 ◦C) and the suspension
was then ﬁltered through a 0.2 m membrane ﬁlter (What-
man  International ltd., Maidstone, UK) prior to injection. All
working solutions and sample solutions were stored at 4 ◦C
before use.
2.4.  Chromatographic  conditions
The simultaneous determination of nine bioactive com-
pounds in YJ was conducted using an Elite Lachrom HPLC-DAD
system equipped with an L-2130 pump, an L-2200 autosam-
pler, an L-2350 column oven, and an L-2455 photodiode array
UV/VIS detector (Lachrom Elite, Hitachi High Technologies Co.,
Tokyo, Japan). The output signal of the detector was recorded
using the EZchrom Elite software (version 3.3.1a, Hitachi High
Technologies Co.,Tokyo, Japan). The separation was achieved
on a C18 column (250 mm × 4.6 mm I.D., 5 m,  RS Tech,
Daejeon, South Korea) and the column temperature was keptd 9, pachymic acid).
at 40 ◦C. The mobile phase consisted of 0.1% TFA (v/v) water (A)
and acetonitrile (B). The gradient elution system, to improve
the chromatographic separation capacity, was programmed
as follows: 10% B (0–5 minutes), 10–20% B (5–15 minutes),
20–27% B (15–20 minutes), 27–37% B (20–35 minutes), 37–53%
B (35–50 minutes), 53–100% B (50–55 minutes), and 100% B
(55–70 minutes) at a ﬂow rate of 1.0 mL/min. The detec-
tion wavelengths for analytes were set at 254 nm and
280 nm and the injection volume of each sample was
10 L.
LC/MS analysis of YJ was performed according to a method
developed previously with some modiﬁcation. All LC/MS spec-
tra for qualitative analysis of nine bioactive compounds were
acquired using an Agilent 1100 series LC/MS system (Agi-
lent 1100+ G1958, agilent technologies, Palo Alto, CA, USA).
Chromatographic separation was performed on a Kinetex C18
(100 mm × 4.6 mm inner diameter (I.D.), 2.6 m,  Phenomenex
Inc., Torrance, CA, USA) by gradient elution, which consisted of
0.1% TFA (v/v) water (A) and acetonitrile (B). The gradient elu-
tion system was programmed as follows: 10% B (0–5 minutes),
10–20% B (5–15 minutes), 20–27% B (15–20 minutes), 27–37%
B (20–35 minutes), 37–53% B (35–40 minutes), 53–100% B
(40–45 minutes), and 100% B (45–60 minutes) at a ﬂow rate of
0.6 mL/min. The conditions of the mass spectrometer anal-
ysis were optimized and were as follows: ionization source
was Atmospheric pressure ionization-electrospray (positive
ion mode), scan mode from m/z 100–900, fragmentor voltage
was set to 60 V, quadrupole was heated to 99 ◦C, capillary volt-
age was set to 3000 V, nebulizer pressure was set at 35 psig,
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rying gas ﬂow was 12.0 L/min, drying gas temperature was
50 ◦C, and the column oven temperature was 40 ◦C.
.5.  Method  validation
he method was validated for selectivity, linearity, precision,
ccuracy, and recovery. Method validation was carried out
ccording to the Validation of Analytical Procedures: Text and
ethodology Q2 (R1) Guideline of the International Confer-
nce on Harmonisation.27
.5.1.  Linearity,  limits  of  detection,  and  limits  of
uantiﬁcation
tandard stock solutions of the nine bioactive compounds
ere diluted with methanol to appropriate concentrations for
lotting the calibration curves. Six different concentrations of
he nine bioactive compounds solution were analyzed in trip-
icate. To demonstrate the linearity of the analytical method,
alibration curves were constructed by plotting the concentra-
ion of each analyte versus the value of the peak. Lower limit
f detection (LLOD) and lower limit of quantiﬁcation (LLOQ)
or each analyte were determined on the basis of S/N of 3.3
nd 10, respectively.
.5.2.  Precision,  accuracy,  and  recovery
he precision of the method was evaluated by intra- and inter-
ay tests. Standard solutions at three different concentrations
ere analyzed. The intraday precision test was performed by
nalyzing a mixed standard solution in ﬁve replicates during
 day. The interday precision test was conducted by analyz-
ng the same standard solution in ﬁve replicates each day
n 3 consecutive days. Precision was expressed as relative
tandard deviation (RSD, %); a value of RSD within 3% is gen-
rally acceptable.
A recovery test was conducted to evaluate the accuracy
f the method. The recoveries of analytes were determined
y adding three different concentrations of each standard
olution into the YJ sample solution (5.0 mg/mL) in triplicate.
ecovery (%) was calculated with the following equation:
ecovery (%) = (found amount − original amount)
/spiked amount × 100. (1)
.  Results
.1.  Optimization  of  chromatographic  conditions
ptimized HPLC-DAD and LC/MS conditions were deter-
ined as follows. Simultaneous qualitative and quanti-
ative analyses of nine bioactive compounds in YJ were
arried out using HPLC-DAD and LC/MS (electrospray ion-
zation MS  ion trap in positive mode). To improve the
hromatographic separation capacity, 0.1% TFA (v/v) water
nd acetonitrile were used as mobile phases with a gradi-
nt elution system. TFA was added to the water to improve
he ionization reaction and to reduce peak tailing; as a result,
he addition of TFA enhanced the separation capacity and143
sensitivity.28 Additionally, acetonitrile was found to have a
better analyte resolution than MeOH.
Identiﬁcation of nine bioactive compounds in YJ was
conducted with an LC/MS analysis. An extracted ion chro-
matogram of the identiﬁed compounds is shown in Fig. 2.
In positive ion mode, molecular ions for each analyte in
the standard mixture were observed at m/z 169.1 [M+H]+ for
homogentisic acid, at m/z 419.0 [M+H]+ for liquiritin, at m/z
581.1 [M+H]+ for naringin, at m/z 611.1 [M+H]+ for hesperidin,
at m/z 611.1 [M+H]+ for neohesperidin, at m/z  257.0 [M+H]+ for
liquiritigenin, at m/z 823.3 [M+H]+ for glycyrrhizin, at m/z  295.1
[M+H]+ for 6-gingerol, and at m/z 529.3 [M+H]+ for pachymic
acid. Under the same conditions, molecular ions for each ana-
lyte in the YJ control sample were detected at m/z 169.0 [M+H]+
for homogentisic acid, at m/z 419.1 [M+H]+ for liquiritin, at m/z
611.1 [M+H]+ for hesperidin, at m/z 257.0 [M+H]+ for liquiriti-
genin, and at m/z 823.2 [M+H]+ for glycyrrhizin (Table 2).
3.2.  Analytical  methods  validation
3.2.1.  Selectivity
The identiﬁcation of the nine bioactives was based on
comparisons of their retention times (tR), UV spectra, and
chromatograms with those of each standard. As shown in
Fig. 3, the retention time of the compounds, homogentisic
acid (1, 5.95 minutes), liquiritin (2, 22.13 minutes), naringin
(3, 24.47 minutes), hesperidin (4, 25.11 minutes), neohes-
peridin (5, 25.81 minutes), liquiritigenin (6, 31.07 minutes),
glycyrrhizin (7, 44.58 minutes), 6-gingerol (8, 51.31 minutes),
and pachymic acid (9, 61.51 minutes) were well separated,
within 60 minutes, and showed good selectivity, without inter-
ference by other analytes. The UV wavelength of the nine
bioactive compounds was optimized according to the max-
imum absorption UV spectrum of each. Analytes (7) and (9)
were detected at 254 nm,  and (1–6) and (8) were detected
at 280 nm.  These results indicated that the method shows
acceptable selectivity and speciﬁcity.
3.2.2.  Linearity,  LLOD,  and  LLOQ
The linearity of the method was assessed in triplicate with
six different concentrations of the standard solutions mixture.
The results of linearity, LLOD, and LLOQ for each analyte are
summarized in Table 3. Excellent linearity of the method was
conﬁrmed by the correlation coefﬁcients (r2 ≥ 0.9995). The val-
ues of LLOD and LLOQ were in the ranges of 0.03–0.17 g/mL
and 0.09–0.43 g/mL, respectively. The results showed that the
calibration curves were within the adequate range and exhib-
ited good sensitivity for the analysis of the nine bioactive
components.
3.2.3.  Precision  and  accuracy
Results of the intra- and interday precision tests are shown in
Table 4. The values of RSD (%) for intra- and interday tests were
within the ranges of 0.09–1.19% and 0.04–1.00%, with accuracy
from 100.38% to 105.86% and 98.12% to 105.43%, respectively.
The values of RSD were < 2.0%, and were thus within the
standards of the guideline.27 These results indicated that this
method was accurate and reliable for all the analytes.
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Fig. 2 – (A) Extracted ion chromatogram (EIC) of the nine components (1, homogentisic acid; 2, liquiritin; 3, naringin; 4,
hesperidin; 5, neohesperidin; 6, liquiritigenin; 7, glycyrrhizin; 8, 6-gingerol, and 9, pachymic acid) in the standard mixture.
(B) EIC of the nine components (1, homogentisic acid; 2, liquiritin; 3, naringin; 4, hesperidin; 5, neohesperidin; 6,
liquiritigenin; 7, glycyrrhizin; 8, 6-gingerol, and 9, pachymic acid) in the Yijin-tang (YJ) sample.
Table 2 – Mass spectral data of the nine analytes
Peak Identiﬁcation Chemical formula Calculated mass Precursor ion
Standard mixture
1 Homogentisic acid C8H8O4 168.0 169.1 [M+H]+
2 Liquiritin C21H22O9 418.1 419.0 [M+H]+
3 Naringin C27H32O14 580.2 581.1 [M+H]+
4 Hesperidin C28H34O15 610.2 611.1 [M+H]+
5 Neohesperidin C28H34O15 610.2 611.1 [M+H]+
6 Liquiritigenin C15H12O4 256.1 257.0 [M+H]+
7 Glycyrrhizin C42H62O16 822.4 823.3 [M+H]+
8 6-Gingerol C17H26O4 294.2 295.1 [M+H]+
9 Pachymic acid C33H52O5 528.4 529.3 [M+H]+
Yijin-tang sample
1 Homogentisic acid C8H8O4 168.0 169.0 [M+H]+
2 Liquiritin C21H22O9 418.1 419.1 [M+H]+
f-YJ samples. The contents of the nine standard compounds4 Hesperidin C28H34O15
6 Liquiritigenin C15H12O4
7 Glycyrrhizin C42H62O16
3.2.4.  Recovery
The average recovery (%) of each analyte showed the accuracy
of this analytical method. The average recovery ranged from
97.65% to 104.50%, and the values of RSD were < 1.43%. These
results are summarized in Table 5. Thus, no signiﬁcant matrix
effect was found, indicating that no internal interference was
detected for any of the analytes.610.2 611.1 [M+H]+
256.1 257.0 [M+H]+
822.4 823.2 [M+H]+
3.3.  Analysis  of  YJ  and  fermented  YJ  samples
The established HPLC-DAD and LC/MS method was used for
analyses of the nine bioactive compounds in YJ control andwere determined with the calibration curves of the stan-
dards. The results of quantitative analyses of the YJ and f-YJ
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Fig. 3 – High-performance liquid chromatography-diode-array detector (HPLC-DAD) chromatogram of the nine components
(1, homogentisic acid; 2, liquiritin; 3, naringin; 4, hesperidin; 5, neohesperidin; 6, liquiritigenin; 7, glycyrrhizin; 8,
6-gingerol, and 9, pachymic acid) in Yijin-tang (YJ) samples. The UV wavelength was set at (A) 254 nm and (B) 280 nm,  (a) YJ
control sample, (b) YJ control sample spiked with standard mixture, (c) standard mixture.
* Unknown peak.
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Fig. 3 – (Continued).
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Table 3 – Calibration curves, lower limit of detection (LLOD) and lower limit of quantiﬁcation (LLOQ) of the nine analytes
Analyte Regression
equation*
Correlation
coefﬁcient (r2)
Linear
range (g)
LLOD
(g/mL)
LLOQ
(g/mL)
Homogentisic acid y = 21,178.81 x + 6,992.74 0.9995 0.28–22.22 0.06 0.18
Liquiritin y = 68,007.99 x + 7,479.75 1.0000 0.28–22.22 0.03 0.10
Naringin y = 62,510.77 x + 6,691.15 1.0000 0.28–22.22 0.05 0.16
Hesperidin y = 60,914.20 x + 27,066.04 1.0000 1.11–88.89 0.06 0.19
Neohesperidin y = 73,062.94 x + 8,067.88 1.0000 0.28–22.22 0.03 0.09
Liquiritigenin y = 90,170.91 x + 9,631.00 1.0000 0.28–22.22 0.04 0.12
Glycyrrhizin y = 22,633.10 x + 13,541.15 0.9997 0.83–66.67 0.17 0.41
6-Gingerol y = 24,815.32 x + 5,641.04 1.0000 0.28–22.22 0.08 0.23
Pachymic acid y = 4,847.30 x – 959.46 1.0000 0.56–44.44 0.14 0.43
∗ Y, peak area; x, concentration (g/mL).
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lamples are shown in Table 6, along with the concentrations
f the nine biomarkers in each sample. Homogentisic acid,
aringin, neohesperidin, and pachymic acid were present
n the HPLC chromatograms of the YJ samples, but their
ontents were below the LLOQ, and so are listed as “nd” (not
etected). As shown in Table 7, fermentation by Lacobacillus
pecies led to a marked decrease in liquiritin and liquiritigenin
evels.
Table 4 – Precision (intra- and interday) and accuracy of the nin
Analyte Analyte
concentration
(g/mL)
Intraday (n = 5
Calculated
concentration
(mean ± SD,
g/mL)
RSD (
Homogentisic acid 2.78 2.82 ± 0.02 0.85
5.56 5.76 ± 0.04 0.75
11.11 11.37 ± 0.06 0.55
Liquiritin 2.78 2.79 ± 0.01 0.25
5.56 5.69 ± 0.07 1.19
11.11 11.42 ± 0.03 0.24
Naringin 2.78 2.87 ± 0.01 0.35
5.56 5.67 ± 0.03 0.61
11.11 11.49 ± 0.01 0.11
Hesperidin 11.11 11.76 ± 0.03 0.27
22.22 23.46 ± 0.16 0.68
44.44 46.39 ± 0.19 0.40
Neohesperidin 2.78 2.86 ± 0.02 0.58
5.56 5.69 ± 0.03 0.59
11.11 11.46 ± 0.02 0.15
Liquiritigenin 2.78 2.90 ± 0.02 0.65
5.56 5.80 ± 0.01 0.13
11.11 11.60 ± 0.05 0.44
Glycyrrhizin 8.33 8.45 ± 0.05 0.57
16.67 17.08 ± 0.01 0.09
33.33 33.70 ± 0.07 0.21
6-Gingerol 2.78 2.85 ± 0.01 0.09
5.56 5.60 ± 0.02 0.33
11.11 11.40 ± 0.04 0.31
Pachymic acid 5.56 5.61 ± 0.03 0.59
11.11 11.15 ± 0.05 0.41
22.22 22.56 ± 0.05 0.21
RSD, relative standard deviation; SD, standard deviation.4.  Discussion
A reliable, simple, and sensitive HPLC-DAD and LC/MS method
was developed for the simultaneous quantitation of nine
biomarkers, including homogentisic acid, liquiritin, naringin,
hesperidin, neohesperidin, liquiritigenin, glycyrrhizin, 6-
gingerol, and pachymic acid in YJ. The HPLC-DAD method was
validated and the results showed good linearity, precision, and
e analytes
) Interday (n = 5)
%) Accuracy
(%)
Calculated
concentration
(mean ± SD,
g/mL)
RSD (%) Accuracy
(%)
 101.69 2.84 ± 0.01 0.16 102.12
 103.61 5.60 ± 0.05 0.91 100.87
 102.34 10.90 ± 0.08 0.75 98.12
 100.60 2.81 ± 0.01 0.40 100.99
 102.34 5.71 ± 0.01 0.13 102.81
 102.82 11.44 ± 0.01 0.04 102.96
 103.45 2.89 ± 0.01 0.25 104.12
 102.08 5.63 ± 0.02 0.43 101.27
 103.40 11.35 ± 0.01 0.09 102.14
 105.86 11.71 ± 0.02 0.17 105.43
 105.55 23.24 ± 0.10 0.41 104.57
 104.38 46.36 ± 0.15 0.33 104.32
 103.08 2.88 ± 0.01 0.20 103.54
 102.47 5.70 ± 0.02 0.38 102.67
 103.10 11.32 ± 0.03 0.26 101.86
 104.31 2.88 ± 0.01 0.31 103.73
 104.48 5.74 ± 0.04 0.61 103.34
 104.41 11.44 ± 0.01 0.04 102.92
 101.37 8.46 ± 0.01 0.15 101.50
 102.50 16.96 ± 0.01 0.06 101.74
 101.09 33.68 ± 0.07 0.20 101.03
 102.65 2.85 ± 0.01 0.20 102.53
 100.84 5.62 ± 0.06 1.00 101.18
 102.58 11.23 ± 0.03 0.30 101.06
 100.98 5.60 ± 0.02 0.42 100.88
 100.38 11.20 ± 0.04 0.37 100.80
 101.32 22.47 ± 0.05 0.22 101.11
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Table 5 – Recoveries of the nine analytes
Analyte Spiked amount
(g/mL)
Measured amount
(g/mL)
RSD (%) Accuracy
(%)
Homogentisic acid 1.39 1.40 ± 0.01 0.15 100.58
2.78 2.82 ± 0.02 0.59 101.44
5.56 5.61 ± 0.02 0.42 101.01
Liquiritin 1.39 1.44 ± 0.01 0.43 103.42
2.78 2.83 ± 0.02 0.74 102.05
5.56 5.81 ± 0.03 0.53 104.50
Naringin 1.39 1.41 ± 0.01 0.22 101.44
2.78 2.85 ± 0.02 0.68 102.68
5.56 5.45 ± 0.01 0.32 98.07
Hesperidin 5.56 5.67 ± 0.04 0.78 102.10
11.11 11.45 ± 0.06 0.54 103.01
22.22 22.99 ± 0.16 0.70 103.46
Neohesperidin 1.39 1.42 ± 0.01 0.79 102.22
2.78 2.83 ± 0.01 0.46 101.82
5.56 5.70 ± 0.01 0.05 102.64
Liquiritigenin 1.39 1.44 ± 0.01 0.47 103.72
2.78 2.85 ± 0.01 0.17 102.55
5.56 5.70 ± 0.02 0.28 102.60
Glycyrrhizin 4.17 4.26 ± 0.05 1.20 102.20
8.33 8.53 ± 0.05 0.56 102.37
16.67 16.74 ± 0.04 0.22 100.45
6-Gingerol 1.39 1.38 ± 0.02 1.43 99.31
2.78 2.78 ± 0.01 0.25 100.03
5.56 5.43 ± 0.04 0.76 97.65
Pachymic acid 2.78 2.81 ± 0.02 0.55 101.08
5.56 5.71 ± 0.02 0.35 102.75
11.11 11.06 ± 0.04 0.37 99.58
RSD, relative standard deviation.
accuracy, with RSD < 2%. Furthermore, no remarkable internal
interferences were detected. The method was applied to the
simultaneous determination of these nine components in YJ
and f-YJ samples. Moreover, biomarkers were identiﬁed and
quantiﬁed based on UV absorbance spectra, retention times,
and mass spectra by comparisons with standard compounds.
The results show that our method is an efﬁcient tool that is
suitable for the quality control of YJ. Note, however, that an
unknown peak in the HPLC-DAD chromatogram (Fig. 3) was
observed at 23.7 minutes. Further study, including chemical
proﬁling of YJ via tandem MS  chromatography and nuclear
magnetic resonance, is required to identify this unknown
material.
To optimize the quality control of YJ, we  selected biomark-
ers for ﬁve herbal medicines within YJ (Table 1). Variations in
the amounts of these nine components in YJ, and f-YJ samples
produced by Lactobacillus KFRI strains, were analyzed and are
compared in Table 6. Hesperidin (for C. unshiu Markovich), 6-
gingerol (for Z. ofﬁcinale Roscoe), and liquiritin, liquiritigenin,
and glycyrrhizin (for G. uralensis Fisch) were detected with
good sensitivity in YJ samples. Hesperidin, a main ﬂavanone
glycoside in C. unshiu Markovich, was the most abundant com-
ponent in YJ samples at 11.98–14.66 mg/g of dry weight.5,6
We  isolated varying amounts of liquiritin, liquiritigenin, and
glycyrrhizin for G. uralensis Fisch, ranging from 0.249 mg/g
to 2.542 mg/g, 0.680 mg/g to 2.660 mg/g, and 3.563 mg/g to
6.305 mg/g of dry weight, respectively. These results suggest
that the detected analytes could be used as YJ biomarkers
for herbal medicines. Unfortunately, homogentisic acid fromP. ternata Breitenbach, naringin and neohesperidin from C.
unshiu Markovich, and pachymic acid from P. cocos Wolf were
not detected in YJ samples. However, the contents of bioactive
compounds in herbal medicines can differ as functions of col-
lection period, region, species, and preparation method.29 This
validated analytical method for naringin, neohesperidin, and
pachymic acid is therefore a useful tool for evaluating C. unshiu
Markovich- and P. cocos Wolf-containing herbal medicines.
In Table 7, liquiritin in f-YJ samples decreased up to ∼90%,
whereas liquiritigenin, its aglycone form increased by 291.08%
compared to the control. According to literature reports, the
deglycosylation activity of glycosides (e.g., liquiritin) is inﬂu-
enced by the activity of -glycosidase, which is produced by
lactic acid bacteria during fermentation.30–32 These ﬁndings
imply that liquiritin is a good indicator of fermentation, as
it is converted to liquiritigenin by Lactobacillus species. The
intestinal absorption of aglycone forms is faster and greater
than their glycosidic equivalents in vivo, thereby increasing
bioavailability and therapeutic efﬁciency.33–36 By contrast, the
concentrations of hesperidin and 6-gingerol in YJ samples
were lower after fermentation. We consider that these com-
ponents were converted into aglycones (e.g., hesperetin, -,
-glycyrrhetinic acid) or other chemical forms by microbial
mechanisms or through enzymatic hydrolysis.31,37 Further
studies should be conducted to elucidate this phenomenon.In conclusion, we established ﬁve biomarkers for YJ-
composed herbal medicines and developed a novel HPLC-DAD
and LC-MS method for the simultaneous determination of
nine biomarkers in YJ. For the purposes of efﬁcient quality
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Table 7 – Conversion rate of liquiritin and liquiritigenin
in fermented-YJ (f-YJ) samples
Strains Conversion rate (%)
Liquiritin Liquiritigenin
Control
Lactobacillus rhamnosus KFRI 144 –89.51 263.14
Lactobacillus acidophilus KFRI 150 –79.09 252.40
Lactobacillus amylophilus KFRI 161 –84.21 232.58
Lactobacillus acidophilus KFRI 162 –85.98 254.62
Lactobacillus plantarum KFRI 166 –90.20 252.06
Lactobacillus acidophilus KFRI 217 –83.01 231.61
Lactobacillus brevis KFRI 221 –85.92 291.08
rLactobacillus. brevis KFRI 227 –85.73 257.94
Lactobacillus curvatus KFRI 231 –84.62 140.47
Lactobacillus acidophilus KFRI 341 –74.72 199.86
control prior to pharmacological evaluation, this HPLC method
was successfully applied to qualitative and quantitative anal-
yses of nine bioactive compounds in YJ and f-YJ.
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